(VIANEWS) – Shares of Castle Biosciences (NASDAQ: CSTL) dropped by a staggering 20.28% in 14 days from $24.46 to $19.50 at 15:13 EST on Monday, after four successive sessions in a row of gains. NASDAQ is dropping 0.37% to $11,761.46, after two sequential sessions in a row of gains.
Castle Biosciences’s last close was $19.71, 75.03% below its 52-week high of $78.92.
Today’s last reported volume for Castle Biosciences is 201386 which is 39.12% below its average volume of 330823.
Castle Biosciences’s Sales
Castle Biosciences’s sales growth is 35% for the current quarter and 48.8% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 113% and a negative 200%, respectively.
Castle Biosciences’s Revenue
Year-on-year quarterly revenue growth grew by 44.7%, now sitting on 94.08M for the twelve trailing months.
Castle Biosciences’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.79%, a negative 1.82%, and a positive 5.20%, respectively.
Castle Biosciences’s highest amplitude of average volatility was 7.24% (last week), 5.00% (last month), and 5.20% (last quarter), respectively.
Castle Biosciences’s Stock Yearly Top and Bottom Value
Castle Biosciences’s stock is valued at $19.50 at 15:13 EST, way under its 52-week high of $78.92 and way above its 52-week low of $17.01.
Castle Biosciences’s Moving Average
Castle Biosciences’s value is way under its 50-day moving average of $32.91 and way below its 200-day moving average of $49.16.
More news about Castle Biosciences (CSTL).